Guidelines recommend treatment with a P2Y 12 platelet adenosine diphosphate receptor
inhibitor … The P2Y 12 inhibitor was initially used for its platelet anti-aggregatory action to block …

… Supplementation of platelets is the most extensively studied strategy for timely reversal of
P2Y 12 inhibition in emergency situation such as acute major bleeding or urgent surgery with …

… Accordingly, our findings cannot be extended to treatment strategies involving other oral
P2Y 12 inhibitors (ie, clopidogrel). Moreover, an indication to early invasive assessment (ie, …

… To assess potential predictive factors for P2Y12 inhibitor switching in patients initially
started on clopidogrel treatment we used modified log-Poisson regression models with robust …

… Assessment of pretreatment with oral P2Y12 inhibitors and cardiovascular and bleeding
outcomes in patients with non-ST elevation acute coronary syndromes". JAMA Netw Open 2021;…

… Hence, underscoring the central role of P2Y12 inhibitors for … the need for more potent P2Y12
inhibitors. We then describe the … We try to rationalize the use of different P2Y12 inhibitors in …

… We compared the effect of P2Y 12 inhibitors on clinical outcomes in patients with acute
coronary syndrome (ACS). Randomized controlled trials comparing clopidogrel, prasugrel, …

… inhibition effect, clinical outcomes, and safety profile than clopidogrel in patients with acute
… overview on the current status in P2Y12 receptor inhibition and to review the pharmacology …

… (PCI) for acute coronary … 12 inhibitor, have been evaluated in several ACS-PCI trials. We
aimed to compare DAPT de-escalation to standard DAPT with full-dose potent P2Y 12 inhibitors …

… P2Y 12 inhibitors have subsequently become the reference therapy in addition to aspirin for
the prevention of acute and subacute stent thrombosis in patients undergoing coronary stent-…